Saniona AB
PRESS RELEASE
March 19, 2021
Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that the Chairman and the CEO, as well as additional members of the Board of Directors and executive management team, have purchased 70,429 shares of the company in the open market for a total value of approximately SEK 1.5 million.
Saniona Chairman of the Board J. Donald deBethizy bought 12,500 shares in the company for a total investment of SEK 262,795. President and CEO Rami Levin bought 10,000 shares in the company for a total investment of SEK 208,400. In addition, a total of 47,929 shares were acquired by the other members of Saniona's Board of Directors and executive management team. All transactions have been made in the open market through broker-assisted trades during the period from 17 March 2021 to 18 March 2021.
For more information, please contact
Trista Morrison, Chief Communications Officer, Saniona. Office: + 1 (781) 810-9227. Email: trista.morrison@saniona.com
The information was submitted for publication, through the agency of the contact person set out above, at 17:30 CET on 19 March 2021.
About Saniona
Saniona is a biopharmaceutical company focused on discovering, developing, and delivering innovative treatments for rare disease patients around the world. The company’s lead product candidate, Tesomet, is in mid-stage clinical trials for hypothalamic obesity and Prader-Willi syndrome, severe rare disorders characterized by uncontrollable hunger and intractable weight gain. Saniona’s robust drug discovery engine has generated a library now consisting of more than 20,000 proprietary modulators of ion channels, a significantly untapped drug class that is scientifically validated. Lead candidate SAN711 is entering Phase 1 for rare neuropathic disorders, with SAN903 for rare inflammatory and fibrotic disorders advancing through preclinical studies. Led by an experienced scientific and operational team, Saniona has an established research organization in Copenhagen, Denmark and is building its corporate office in the Boston, Massachusetts area, U.S. The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at www.saniona.com.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Alvotech4.7.2025 01:02:13 CEST | Press release
Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuers
RIB Software3.7.2025 21:17:25 CEST | Press release
RIB Software Recognized as a Leader for Construction Management Software by Independent Research Firm
Solvay S.A.3.7.2025 18:00:00 CEST | Press release
Participation notification by Morgan Stanley
Siili Solutions Oyj3.7.2025 17:30:00 CEST | Press release
Siili Solutions Plc: Share Repurchase 3.7.2025
Virtune AB (Publ)3.7.2025 15:29:54 CEST | Press release
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for June 2025 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom